Flyer

Translational Biomedicine

  • ISSN: 2172-0479
  • Journal h-index: 12
  • Journal CiteScore: 8.06
  • Journal Impact Factor: 1.0
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
20+ Million Readerbase
Indexed In
  • Open J Gate
  • Genamics JournalSeek
  • JournalTOCs
  • ResearchBible
  • The Global Impact Factor (GIF)
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Electronic Journals Library
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Proquest Summons
  • Publons
  • MIAR
  • University Grants Commission
  • Geneva Foundation for Medical Education and Research
  • Google Scholar
  • Secret Search Engine Labs
  • ResearchGate
Share This Page

Abstract

A Self-Assembled Non-Viral vector as Potential Platform for mRNA-Based Vaccines

Stefano Persano

Here, we show a universal anti-cancer vaccine, based on antigen-mRNA-loaded self-assembled polyplex nanocarrier. The establishment of antigen-specific T-cells, as consequence of the vaccination, performed following a subcutaneous route of administration, was confirmed by detection of IFN-γ/IL-2 producing T-cells in the spleen of the treated mice. Moreover, a high release of Th1-releated IgG isotypes (IgG2b and IgG2c) was observed, indicating a predominantly Th1 response. Finally, OVA-mRNA-based vaccine formulation has been employed for the treatment of melanoma lung metastasis of B16-OVA challenged mice, inducing a marked reduction of metastatic nodules up to 93%. Ascertained that any polypeptide-based antigen can be encoded as RNA, potentially our platform can represent a universal strategy suitable for the development of any mRNA-based vaccine.